Microbial antigen treatment in sarcoidosis - A new paradigm?

Medical Hypotheses

Volumn 70, Issue 4, 2008, Pages 831-834

  Terčelj, Marjeta ^a   Salobir, Barbara ^a   Rylander, Ragnar ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b BioFact Environmental Health Research Center   (Sweden)

Author keywords

1,2 glucan; Granuloma; Microbes; Microbial cell wall agents; Sarcoidosis

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; CORTICOSTEROID DERIVATIVE; TETRACYCLINE DERIVATIVE;

ARTICLE; FOLLOW UP; FUNGUS GROWTH; GRANULOMA; HUMAN; HYPERSENSITIVITY REACTION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS;

ADRENAL CORTEX HORMONES; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGENS, BACTERIAL; CELL WALL; DRUG RESISTANCE; ENVIRONMENT; GRANULOMA; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; SARCOIDOSIS;

EID: 39849110454     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.07.034     Document Type: Article

References (32)

1. Ota M., Amakawa R., Uehira K., Ito T., Yagi Y., Oshiro A., et al. Involvement of denditric cells in sarcoidosis. Thorax 59 (2004) 408-413
2. Dai H., Guzman J., Chen B., and Costabel U. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-α by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis. Chest 127 (2005) 251-256
3. Martin II W.J., Iannuzzi M.C., Gail D.B., et al. Future directions in sarcoidosis research Summary of an NHLBI working group. Am J Resp Crit Care Med 170 (2004) 567-571
4. Marshall T.G., and Marshall F.E. Sarcoidosis sucumbs to antibiotics - implications for autoimmune disease. Autoimmun Rev 3 (2004) 295-300
5. Bradford Hill A. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 285-300
6. Newman L.S., Rose C.S., Bresnitz E.A., and the ACCESS research group. A case-control etiological study of sarcoidosis - environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
7. Kucera G.P., Rybicki B.A., Kirkey K.L., Coon S.W., Major M.L., Maliarik M.J., et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest 123 (2003) 1527-1535
8. Li N., Bajohgli A., Kubba A., and Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol 26 (1999) 271-278
9. Bajoghli L.N., Kubba A., and Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol 26 (1999) 271-278
10. Rizik S.N. Acute anterior uveitis in a patient with sarcoidosis and toxoplasma dye test titre. Br J Ophtalmol 49 (1965) 34-36
11. Kociecka W., Simon E., Pakula M., and Fundowicz D. Sarcoidosis in coexistence with Toxoplasma gondii invasion. Pol Tyg Lek 47 (1992) 805-807
12. McFarland R.B., and Goodman S.B. Sporotrichosis and sarcoidosis. Arch Int Med 112 (1963) 174-179
13. Shields L.H. Disseminated cryptococcosis producing a sarcoid type reaction. AMA Arch Intern Med 104 (1959) 763
14. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40 (2002) 198-204
15. Cantwell A.R. Bacteria in sarcoidosis and a rationale for antibiotic therapy in this disease. JOIRM 1 (2003) 1
16. Brown S.T., Brett I., Almenoff P.L., Cesser M., Terrin M., and Tierstein A.S. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 123 (2003) 413-417
17. Song Z., Marzilli L., Greenlee B.M., Chen E.S., Silver R.F., and Askin F.B. Mycobacterial catalase-peroxides is a tissue antigen and target of the adaptive immune response in systematic sarcoidosis. J Exp Med 201 (2005) 755-767
18. Silzbach L.E., and Teirstein A.S. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand 425 (1964) 302S-308S
19. Bachelez H., Senet P., Cadranel J., Kaoukhov A., and Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137 (2001) 69-73
20. Baba K., Yamaguchi E., Matsui S., Niwa S., Onoe K., Yagi T., et al. A case of sarcoidosis with multiple endobronchial mass lesions that disappear with antibiotics. Sarcoidosis Vasc Diffuse Lung Dis 23 (2006) 78-79
21. Tercelj M., Rott T., and Rylander R. Antifungal treatment in sarcoidosis - a pilot intervention trial. Resp Med 101 (2007) 774-778
22. Baughman R.P., and Lower E.E. Fungal infections as a complication of therapy for sarcoidosis. Q J Med 98 (2005) 451-456
23. Labro M.T. Interaction of antibacterial agents with host respiratory defeces. Eur Resp Mon 28 (2004) 45-63
24. Pignone A.M., Rosso A.D., Fiori G., Matucci-Cerinic M., Becucci A., Tempestini A., et al. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. J Pineal Res 41 (2006) 95-100
25. Song Z., Marzilli L., Greenlee B.M., Chen E.S., Silver R.F., and Askin F.B. Mycobacterial catalase-peroxidase in a tissue antigen and target of the adaptive immune response in systematic sarcoidosisi. J Exp Med 201 (2005) 755-767
26. Rylander R. Role of endotoxin and glucan for the development of granulomatous disease in the lung. Sarcoidosis 6 (1989) 26-27
27. Rylander R. (1→3)-β-D-glucan in the environment: a risk assessment. In: Young S.-H., and Castranova V. (Eds). Toxicology of (1→3)-β-glucans: glucans as a marker for fungal exposure (1995), CRC press, Boca Raton FA 53-64
28. Johnson K.J., Glovsky M., and Schrier D. Pulmonary granulomatous vasculitis induced in rats by treatment with glucan. Am J Pathol 114 (1984) 515-516
29. Svercek P.S., Mojzisova J., Durove A., Benisek Z., and Huska M. The immunomodulatory effect of the soluble fungal glucan (Pleurotus ostreatus) on delayed hypersensitivity and phagocytic ability of blood leucocytes in mice. Zentralbl Veterinärmed B 43 (1966) 129-135
30. + T cells and dendritic cells in vivo. J Exp Med 203 (2006) 505-511
31. Beijer L., Thorn J., and Rylander R. Mould exposure at home relates to inflammatory markers in blood. Eur Respir J 21 (2003) 317-322
32. Grutters J.C., and van den Bosch J.M.M. Corticoid treatment in sarcoidosis. Eur Resp J 28 (2006) 627-636